Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0028 Advanced Bladder 7/1/2001 12/15/2006 81%
    Closed S0027 Vinorel/Doc/Adv NSCLC/Age >=70 PS 0-1/PS 2 any age; Selected IIIB & IV 9/1/2001 7/1/2003 100% Published
    Closed S0026 IFN & Thalidomide in Disseminated Malignant Melanoma 11/1/2001 5/1/2003 62% Published
    Closed S0025 OVARIAN 2/15/2003 8/15/2003 5%
    Closed S0023 Cis/VP-16/RT/Consol. Doc followed by ZD1839/Placebo /IIIA & selected IIIB NSCLC 6/15/2001 4/15/2005 74% Published
    Closed S0022 Cis/Doc/RT followed by Consolidation Doc in NSCLC; Stage IIIB 3/15/2001 2/1/2003 33%
    Closed S0020 ATG for MDS 8/15/2001 5/15/2003 16%
    Closed S0019 NON-HODGKIN'S: ICE +/- Rituxan for Relapsed/Refractory CD20+ B-Cell NHL 10/15/2000 12/15/2001 2% Published
    Closed S0016 NON-HODGKIN'S: CHOP/rituximab vs. CHOP/tositumomab 3/1/2001 10/2/2008 100% Published
    Closed S0014 NON-HODGKIN'S: CHOP with concurrent rituximab plus IFR 4/1/2000 1/15/2002 100% Published
    Closed S0013 CERVICAL 9/15/2000 11/15/2003 36% Published
    Closed S0012 NEOADJUVANT: Standard AC vs. Weekly A and Daily Oral C + G-CSF 5/1/2001 12/1/2005 100% Published
    Closed S0011 Squamous cell carcinoma 3/1/2003 7/1/2006 22% Published
    Closed S0010 Relapsed/Refractory Non T-Cell ALL 7/15/2000 3/15/2004 48%
    Closed S0009 OVARIAN 3/15/2001 2/1/2006 100% Published
    Closed S0008 High Dose IFN vs. Cis/Vinblastine/DTIC + IL-2 & IFN in High Risk Melanoma 8/1/2000 11/15/2007 90% Published
    Closed S0007 Advanced, Recurrent, or Metastatic 11/1/2000 5/15/2003 100% Published
    Closed S0004 Tirapazamine/Cis/Etopo/RT in Limited SCLC 10/15/2000 4/1/2002 60% Published
    Closed S0003 Carbo/Pac + Tirapazamine vs. Carbo/Pac in Adv. NSCLC; Selected IIIB & IV 11/15/2000 11/15/2002 72% Published
    Closed S0002 Smoking Cessation Stage I & II NSCLC 1/1/2002 1/1/2004 2%
    Scroll Table